Table 6 Included studies comparing cardiac parameters (Structure, function, tissue characterization, and perfusion) between patients with mild COVID-19 syndrome and COVID-negative healthy controls
Author | Time since diagnosis | Case/Control number | Cardiac parameters tested | Study findings |
|---|---|---|---|---|
Gorecka [23] |  > 12 weeks | 20/10 | Myocardial energetics: phosphocreatine to ATP ratio Cardiac structure: biventricular volumes Cardiac function: biventricular ejection fractions and global longitudinal strain Tissue characterization: T1 mapping and late gadolinium enhancement Perfusion: myocardial rest and stress blood flow, and myocardial perfusion reserve | No significant difference |
Joy [24] | 6 months | 74/75 | Cardiac structure: left ventricular volumes, mass, and atrial area Cardiac function: ejection fraction, global longitudinal shortening, and aortic dispensability Tissue characterization: T1, T2, extracellular volume fraction mapping, and late gadolinium enhancement Biomarkers: troponin, and N-terminal pro–B-type natriuretic peptide | No significant difference |